Bosh sahifaSLNCF • OTCMKTS
add
Silence Therapeutics plc
Yopilish kursi
0,95 $
Yillik diapazon
0,50 $ - 14,75 $
Bozor kapitalizatsiyasi
174,73 mln USD
Oʻrtacha hajm
9,53 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 25,55 mln | 1 180,58% |
Joriy xarajat | 16,51 mln | 144,71% |
Sof foyda | 10,34 mln | 159,17% |
Sof foyda marjasi | 40,47 | 104,62% |
Har bir ulushga tushum | — | — |
EBITDA | 6,92 mln | 214,46% |
Amaldagi soliq stavkasi | 46,54% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 147,33 mln | 114,18% |
Jami aktivlari | 202,64 mln | 69,64% |
Jami passivlari | 68,61 mln | -29,60% |
Umumiy kapital | 134,02 mln | — |
Tarqatilgan aksiyalar | 47,22 mln | — |
Narxi/balansdagi bahosi | 0,33 | — |
Aktivlardan daromad | 8,17% | — |
Kapitaldan daromad | 13,41% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 10,34 mln | 159,17% |
Operatsiyalardan naqd pul | -27,62 mln | -91,10% |
Sarmoyadan naqd pul | 62,32 mln | 5 532,17% |
Moliyadan naqd pul | 1,40 mln | -88,85% |
Naqd pulning sof oʻzgarishi | 42,62 mln | 1 757,25% |
Boʻsh pul | -2,14 mln | -67,96% |
Haqida
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
Tashkil etilgan
1994
Xodimlar soni
116
